Does Vitamin D Help With Dizziness and Vertigo?

Vitamin D supplementation has meaningful evidence behind it for one specific type of vertigo: benign paroxysmal positional vertigo, or BPPV, the most common vestibular disorder. People with low vitamin D who experience recurring BPPV episodes appear to have roughly half the recurrence rate when they take supplements. The picture is less clear for other forms of dizziness, though emerging research links vitamin D deficiency to orthostatic hypotension and vestibular nerve inflammation. Whether supplements help you depends heavily on what is causing your dizziness and whether your vitamin D is actually low.

BPPV and the Inner Ear Crystal Problem

BPPV is the kind of vertigo where the room suddenly spins when you roll over in bed, tilt your head back, or bend down. It happens when tiny calcium carbonate crystals called otoconia break loose from their normal position in the inner ear and drift into the semicircular canals, where they do not belong. Those displaced crystals slosh around and send false motion signals to your brain, triggering brief but intense spinning episodes that usually last less than a minute.

Vitamin D enters the picture because it plays a direct role in how those crystals are formed and maintained. Calcium and vitamin D metabolism in the inner ear are involved in both the creation and the gradual breakdown of otoconia over time.¹ When vitamin D drops too low, the quality of those crystals may degrade, making them more likely to fragment and drift into the wrong part of the ear. Research on mice has found that when the vitamin D receptor is knocked out entirely, expression of key otolith-associated proteins drops sharply in inner ear tissue.² The connection is not abstract: BPPV patients consistently show lower vitamin D levels and lower expression of the vitamin D receptor compared to people without the condition.

Does Vitamin D Supplementation Actually Reduce BPPV Recurrence?

The strongest evidence comes from intervention trials rather than just observational studies. A 2025 meta-analysis pooling data from multiple trials found that the vitamin D supplementation group had a substantially lower recurrence rate than the control group, with a relative risk of 0.45, meaning roughly a 55% reduction in the odds of BPPV coming back.³ That effect was specifically seen in patients who were vitamin D insufficient to begin with.

One well-designed randomized trial tracked patients for two full years. BPPV recurrence in the group taking vitamin D (cholecalciferol) was about 28% over 24 months, compared to 55% in the placebo group, a 50% relative risk reduction. The number needed to treat was under four, meaning for roughly every four people supplemented, one additional person avoided a recurrence.⁴ Those are strong numbers for a relatively cheap, low-risk intervention.

An earlier systematic review from 2024 confirmed that BPPV patients tend to have lower vitamin D than controls, but was less certain about whether vitamin D levels predict who will get recurrent episodes versus a one-time event.⁵ In other words, low vitamin D is clearly associated with getting BPPV in the first place, but the question of whether it specifically predicts which patients will suffer repeated bouts has been harder to nail down in pooled analyses. The intervention data, however, consistently shows supplementation helps once you are in the “recurrent BPPV” category.

Severity and Deficiency

The relationship is not just about whether BPPV happens at all. A study comparing patients with vitamin D deficiency (below 20 ng/mL) to those with sufficient levels found that about 71% of deficient patients had BPPV, compared to 20% of those with adequate vitamin D. The deficient group also reported higher symptom severity scores.⁶ So it is not just that low vitamin D nudges the odds slightly. People with outright deficiency seem to experience more frequent and more intense episodes.

A separate study focusing specifically on supplementation found that all enrolled BPPV patients had serum vitamin D below 20 ng/mL. When one group received vitamin D while both groups received standard repositioning treatment, recurrent episodes were significantly lower in the supplemented group.⁷ The takeaway from these studies together: supplementation seems most relevant if your vitamin D is genuinely low, not as a universal vertigo remedy for people with normal levels.

Why BPPV Peaks in Winter

An interesting piece of supporting evidence comes from seasonal data. A systematic review published in 2025 found that nine out of eleven studies reported seasonal variation in BPPV, with cases clustering in winter months.⁸ Winter is precisely when most people’s vitamin D levels hit their lowest point, since the skin produces far less of it with reduced sun exposure.

A six-year registry study in Shanghai tracked this more precisely. December through March were the peak months for BPPV presentations. Median vitamin D levels in the winter group were substantially lower than in the summer group (about 16 versus 21 ng/mL), and there was a moderate negative correlation between monthly vitamin D levels and the number of BPPV patients seen each month.⁹ When vitamin D dropped, BPPV cases rose. Correlation is not causation, but the seasonal pattern is consistent with the proposed mechanism of vitamin D supporting otoconia integrity.

The Osteoporosis Link

Bone density adds another dimension to this story. Vitamin D is well known for its role in calcium absorption and bone health, and osteoporosis shares some metabolic pathways with otoconia degeneration. A study of BPPV patients found that those who also had osteoporosis had a recurrence rate of about 56%, compared to only 16% in patients with normal bone mineral density. The recurrence rate rose as bone density fell.¹⁰

This matters because it suggests that the same metabolic processes eroding your skeleton may be eroding the tiny calcium crystals in your inner ear. Postmenopausal women, who face higher rates of both osteoporosis and BPPV, may be especially susceptible. If you are already treating bone density loss with vitamin D and calcium, that regimen may be pulling double duty for your inner ear as well.

Beyond BPPV: Vestibular Neuritis

BPPV gets most of the research attention because it is the most common vestibular disorder, but vitamin D may matter for other forms of vertigo too. Vestibular neuritis is an inflammation of the vestibular nerve that causes sudden, severe vertigo lasting days, often thought to be triggered by reactivation of latent herpes simplex virus in the vestibular ganglion. A study found that patients with vestibular neuritis had lower vitamin D levels than controls, and the authors proposed that normal vitamin D levels may help regulate the inflammatory response in the inner ear. When vitamin D is low, the thinking goes, the body’s ability to suppress inflammation weakens, potentially allowing viral reactivation to cause more nerve damage.¹¹

This is more speculative than the BPPV data. No randomized trials have tested whether giving vitamin D to people with vestibular neuritis changes their outcomes. The hypothesis is plausible, given vitamin D’s well-documented anti-inflammatory properties, but it remains a hypothesis for now.

Orthostatic Dizziness and Blood Pressure Drops

Not all dizziness is vertigo. A lot of people experience lightheadedness when they stand up too quickly, a condition called orthostatic hypotension, where blood pressure temporarily drops. This is a common complaint in older adults, and here too vitamin D seems to play a role.

A study in older women found that those with vitamin D deficiency were roughly three and a half times more likely to have orthostatic hypotension than those with adequate levels. There was also a dose-response relationship: the lower the vitamin D, the larger the drop in blood pressure upon standing.¹² A separate study in older men from the British Regional Heart Study found a similar pattern: men with vitamin D deficiency were about 50% more likely to have early orthostatic hypotension, the kind that hits within the first minute of standing.¹³

However, observational studies showing an association do not prove that taking supplements fixes the problem. The STURDY trial, a randomized trial in older adults, tested whether vitamin D supplementation could prevent orthostatic hypotension. While the rationale was built on solid observational evidence linking low vitamin D to blood pressure drops on standing, the trial’s findings were less encouraging for a straightforward supplementation recommendation.¹⁴ The gap between “low vitamin D correlates with more dizziness on standing” and “taking vitamin D pills will stop the dizziness” remains partially open for this particular type of lightheadedness.

Falls and Balance in Older Adults

For older adults, dizziness is not just uncomfortable; it is dangerous. Falls are a leading cause of injury in people over 65, and anything that reduces fall risk has real consequences for health and independence. A meta-analysis of vitamin D supplementation and falls found that daily doses of at least 700 IU reduced the risk of falling by about 13% compared to placebo. The number needed to treat was 17, meaning 17 people had to take vitamin D for one additional fall to be prevented. Doses below that threshold showed no benefit.¹⁵

The fall prevention effect likely works through multiple pathways. Some of the benefit probably comes from improved muscle function, since vitamin D receptors are present in skeletal muscle tissue. But given what we know about BPPV and orthostatic hypotension, reduced dizziness may be part of the equation too. Older adults with better vitamin D status may simply experience fewer of the sudden disorienting moments that cause a stumble.

Dosing and Practical Considerations

If you are dealing with recurrent BPPV and your doctor confirms low vitamin D, supplementation is a reasonable add-on to standard repositioning maneuvers like the Epley maneuver. Most of the clinical trials used weekly doses equivalent to about 1,000 IU per day. One study supplemented patients with 7,000 IU per week and saw serum levels rise by about 11 ng/mL over six months, though no further increase was observed by the 12-month mark, suggesting the dose may plateau at a certain level.¹⁶ The optimal target level for preventing BPPV recurrence has not been definitively established, which is something researchers have flagged as a gap.

It is worth knowing that vitamin D supplementation is not a quick fix for an active vertigo episode. The repositioning maneuvers that physically move displaced otoconia out of the semicircular canals remain the first-line treatment for BPPV and work within minutes. Vitamin D supplementation is a longer-term preventive strategy aimed at reducing how often the crystals dislodge in the first place. Think of it as maintenance rather than emergency repair.

Getting your vitamin D level tested before supplementing is a good idea. The benefits in the studies were seen in people who were deficient or insufficient (generally below 20 ng/mL). There is no convincing evidence that pushing vitamin D levels higher in people who are already at normal levels provides any extra protection against vertigo. And high-dose supplementation without monitoring carries its own risks, including potential problems with calcium metabolism.

When Vitamin D Probably Will Not Help Your Dizziness

Dizziness is a notoriously vague symptom with dozens of possible causes, and vitamin D is only relevant to a subset of them. If your dizziness comes from medication side effects, anxiety, inner ear fluid problems like Ménière’s disease, migrainous vertigo, cardiac arrhythmias, or neurological conditions, vitamin D supplementation is unlikely to address the root cause. The evidence is concentrated around BPPV, with preliminary signals for orthostatic hypotension and vestibular neuritis but nothing strong enough to guide clinical decisions for those conditions yet.

Even within BPPV, supplementation is not a replacement for diagnosis. Some people assume any room-spinning sensation is BPPV and start popping vitamin D on their own. But central vertigo caused by problems in the brain rather than the ear can mimic BPPV, and treating it with supplements while ignoring the real cause could be dangerous. If your vertigo is new, severe, or accompanied by symptoms like slurred speech, difficulty walking, or double vision, you need a medical evaluation, not a bottle of supplements.

Why the Research Is Concentrated in Certain Populations

Most BPPV studies have been conducted in regions with high rates of vitamin D deficiency, including parts of East Asia, the Middle East, and South Asia. Study populations tend to skew older and to include more women than men, reflecting the demographics of BPPV itself. This means the evidence is strongest for older women with documented vitamin D deficiency who live in places where deficiency is common. Whether the same effect size applies to younger men with borderline-normal vitamin D in sunnier climates is simply not known yet.

Researchers have also raised the challenge of working with small sample sizes. Because awareness of vitamin D has grown so rapidly, many potential study participants are already taking supplements on their own, which shrinks the pool of eligible subjects and makes it harder to run large trials.¹⁶ Multicenter trials are needed but logistically difficult to organize for a condition that, while very common, is not life-threatening.

The broader question of whether vitamin D deficiency is a cause of BPPV or simply a common companion is also still being debated. Both BPPV and vitamin D deficiency are extremely prevalent in older adults, and they share risk factors like aging, reduced mobility, and less time outdoors. Disentangling a direct causal pathway from a shared set of underlying risk factors is the kind of problem that takes years of carefully designed trials to resolve.